Multomic analysis reveals the potential of LAG3 as a prognostic and immune biomarker and its validation in osteosarcoma
Favorite
Share
More Options
24

Open in WPS to view all 24 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
